Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PET imaging of oestrogen receptors in patients with breast cancer.
van Kruchten M, de Vries EGE, Brown M, de Vries EFJ, Glaudemans AWJM, Dierckx RAJO, Schröder CP, Hospers GAP. van Kruchten M, et al. Lancet Oncol. 2013 Oct;14(11):e465-e475. doi: 10.1016/S1470-2045(13)70292-4. Lancet Oncol. 2013. PMID: 24079874 Review.
Molecular imaging for monitoring treatment response in breast cancer patients.
Bensch F, van Kruchten M, Lamberts LE, Schröder CP, Hospers GA, Brouwers AH, van Vugt MA, de Vries EG. Bensch F, et al. Among authors: van kruchten m, van vugt ma. Eur J Pharmacol. 2013 Oct 5;717(1-3):2-11. doi: 10.1016/j.ejphar.2013.01.079. Epub 2013 Mar 30. Eur J Pharmacol. 2013. PMID: 23545359 Review.
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Koleva-Kolarova RG, Greuter MJ, van Kruchten M, Vermeulen KM, Feenstra T, Buskens E, Glaudemans AW, de Vries EF, de Vries EG, Hospers GA, de Bock GH. Koleva-Kolarova RG, et al. Among authors: van kruchten m. Br J Cancer. 2015 May 12;112(10):1617-25. doi: 10.1038/bjc.2015.138. Epub 2015 Apr 16. Br J Cancer. 2015. PMID: 25880006 Free PMC article.
Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.
van Kruchten M, Glaudemans AWJM, de Vries EFJ, Schröder CP, de Vries EGE, Hospers GAP. van Kruchten M, et al. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1674-1681. doi: 10.1007/s00259-015-3107-5. Epub 2015 Jun 20. Eur J Nucl Med Mol Imaging. 2015. PMID: 26091705 Free PMC article. Clinical Trial.
26 results